Aortic dissection repair with false lumen embolization
Part of Heart & circulation clinical trials.
This trial tests a new approach for treating type B aortic dissections by combining stent placement with a technique to close off the false channel. It aims to improve outcomes for patients who are not in crisis and whose dissection extends into the belly area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type B aortic dissection that started within the last 30 days (acute or subacute).
- You have typical symptoms and your diagnosis is confirmed by imaging.
- The dissection goes down past the kidney arteries into the lower abdominal aorta.
- You are scheduled for elective TEVAR (stent repair) combined with false lumen embolization.
- You are between 18 and 80 years old.
- You have not had prior aortic surgery or stent repair.
- You have not had a heart attack or stroke in the last 6 months.
- You do not have uncontrolled diseases like advanced cancer or severe organ failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining a standard stent graft with longer bare-metal stents to treat a type of aortic dissection within two weeks of symptoms starting. It aims to see if the combination is safe and works better than current options.
This trial tests a special plug (WeFlow-EndoSeal) placed into the false channel of a type B aortic dissection to help seal it. It is for people who are already getting a stent-graft and aims to improve the repair.
This study tests a minimally invasive procedure called TEVAR to repair a type B aortic dissection (a tear in the wall of the main artery from your heart). It may help prevent further damage and improve recovery.
This study tests whether a stent procedure (TEVAR) can improve blood flow and healing in people with a serious aortic tear (type B dissection). It may be an option if you have complications or high-risk features from the dissection.
This trial is collecting data on patients with type B aortic dissection who undergo a minimally invasive procedure called TEVAR. The goal is to improve quality and outcomes for future patients. If you had this procedure, you might be eligible to join.
This trial studies which treatment is best for people with a recent, “uncomplicated” type B aortic dissection (a tear in the aorta). It may help doctors choose safer care for patients whose dissection has not yet caused major complications.
Hear when a new Aortic Dissection Type B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.